LXRX

1.42

3.40% -0.05

Dopo l'orario di chiusura: 1.42

Lexicon Pharmaceuticals Inc (LXRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché LXRX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.47

Aprire:

$1.44

Volume 24 ore:

1.69M

Relative Volume:

0.66

Capitalizzazione di mercato:

$516.03M

Reddito:

$1.21M

Utile/perdita netta:

$-177.12M

Rapporto P/E:

-1.775

EPS:

-0.8

Flusso di cassa netto:

$-162.37M

1 W Prestazione:

-4.70%

1M Prestazione:

+30.28%

6M Prestazione:

+178.54%

1 anno Prestazione:

-29.35%

Intervallo 1D:

$1.39

$1.46

Intervallo di 1 settimana:

$1.39

$1.58

Portata 52W:

$0.2836

$2.175

Lexicon Pharmaceuticals Inc Stock (LXRX) Company Profile

Nome

Lexicon Pharmaceuticals Inc

Settore

Healthcare (1134)

Industria

Biotechnology (636)

Telefono

(281) 863-3000

Indirizzo

2445 TECHNOLOGY FOREST BLVD., THE WOODLANDS

Dipendente

103

Cinguettio

@LexPharma

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

LXRX's Discussions on Twitter

Confronta LXRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LXRX Lexicon Pharmaceuticals Inc	1.42	534.20M	1.21M	-177.12M	-162.37M	-0.80
VRTX Vertex Pharmaceuticals Inc	416.81	104.76B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.67	63.06B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	578.05	60.32B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	843.66	51.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	165.76	34.49B	398.11M	-1.03B	-868.57M	-5.7032

Lexicon Pharmaceuticals Inc Stock (LXRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-05	Downgrade	Leerink Partners	Outperform → Market Perform
2024-06-17	Iniziato	H.C. Wainwright	Buy
2024-04-30	Iniziato	Leerink Partners	Outperform
2023-03-07	Iniziato	Jefferies	Hold
2022-08-12	Iniziato	Piper Sandler	Overweight
2021-01-29	Aggiornamento	JP Morgan	Underweight → Neutral
2021-01-29	Downgrade	Wedbush	Outperform → Neutral
2020-12-08	Aggiornamento	Citigroup	Neutral → Buy
2020-11-18	Aggiornamento	Gabelli & Co	Hold → Buy
2019-12-11	Downgrade	Gabelli & Co	Buy → Hold
2019-11-08	Downgrade	Citigroup	Buy → Neutral
2019-09-11	Aggiornamento	Gabelli & Co	Hold → Buy
2019-07-29	Downgrade	Stifel	Buy → Hold
2019-03-25	Aggiornamento	Gabelli & Co	Sell → Hold
2018-07-31	Reiterato	Stifel	Buy
2018-02-23	Downgrade	Needham	Buy → Hold
2018-02-14	Downgrade	JP Morgan	Neutral → Underweight
2017-03-01	Reiterato	H.C. Wainwright	Buy
2017-03-01	Reiterato	Wedbush	Outperform
2016-10-07	Iniziato	H.C. Wainwright	Buy
2016-08-05	Reiterato	Wedbush	Outperform
2016-08-02	Iniziato	Citigroup	Buy
2016-03-02	Reiterato	Wedbush	Outperform
2015-11-09	Reiterato	Wedbush	Outperform
2015-09-28	Aggiornamento	Gabelli & Co	Sell → Hold
2015-09-18	Downgrade	Gabelli & Co	Hold → Sell
2015-08-10	Downgrade	JP Morgan	Overweight → Neutral

Mostra tutto

Lexicon Pharmaceuticals Inc Borsa (LXRX) Ultime notizie

Oct 18, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsSwing Trade & Daily Price Action Insights - newser.com

Oct 18, 2025

Is Lexicon Pharmaceuticals Inc. building a consolidation baseWeekly Trend Summary & Low Risk Entry Point Guides - newser.com

Oct 18, 2025

Is Lexicon Pharmaceuticals Inc. stock a defensive play in 20252025 Market Overview & Comprehensive Market Scan Reports - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 17, 2025

How analysts rate Lexicon Pharmaceuticals Inc. stock todayJuly 2025 EndofMonth & Community Trade Idea Sharing - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025

Lexicon Pharmaceuticals Inc Stock Analysis and ForecastSector Leadership Analysis & Affordable Growth Strategies - earlytimes.in

Oct 17, 2025

Oct 14, 2025

Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit - The Manila Times

Oct 14, 2025

Short interest data insights for Lexicon Pharmaceuticals Inc.2025 Geopolitical Influence & AI Enhanced Trading Signals - newser.com

Oct 14, 2025

Oct 10, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8% HigherWhat's Next? - MarketBeat

Oct 10, 2025

Lexicon Pharmaceuticals' (LXRX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 08, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Down 6.3%Time to Sell? - MarketBeat

Oct 08, 2025

Lexicon (LXRX) Engages in Policy Discussion to Tackle Chronic Pa - GuruFocus

Oct 08, 2025

Lexicon Pharmaceuticals Hosts Roundtable on Legislative Solutions for Chronic Pain Management - Quiver Quantitative

Oct 08, 2025

Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain - MarketScreener

Oct 08, 2025

Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People With Chronic Pain - 富途牛牛

Oct 08, 2025

Oct 06, 2025

Detecting price anomalies in Lexicon Pharmaceuticals Inc. with AIEarnings Beat & Intraday High Probability Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Can you recover from losses in Lexicon Pharmaceuticals Inc.2025 Analyst Calls & Safe Entry Point Identification - newser.com

Oct 05, 2025

Is Lexicon Pharmaceuticals Inc. a candidate for recovery playPortfolio Value Summary & Consistent Income Trade Recommendations - newser.com

Oct 05, 2025

Oct 04, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Oct 04, 2025

Oct 03, 2025

Is Lexicon Pharmaceuticals Inc. stock bottoming out2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com

Oct 03, 2025

What’s the recovery path for long term holders of Lexicon Pharmaceuticals Inc.Portfolio Return Summary & Long-Term Capital Growth Ideas - newser.com

Oct 03, 2025

Smart tools for monitoring Lexicon Pharmaceuticals Inc.’s price actionGap Up & High Accuracy Investment Signals - newser.com

Oct 03, 2025

Oct 02, 2025

Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) After Shares Rise 28% - simplywall.st

Oct 02, 2025

Sep 30, 2025